53 / 100

Assoc Prof Dr. Elaheh Mosaddegh, Medicinal Chemistry Award, Best Researcher Award

Associate Professor at Graduate University of Advanced Technology, Iran

Assoc Prof Dr. Elaheh Mosaddegh is a distinguished academician, researcher, and pharmaceutical industry professional specializing in organic chemistry and medicinal chemistry. With a Ph.D. in Organic Chemistry from Shahid Bahonar University of Kerman, Dr. Mosaddegh has established herself as an expert in multi-component reactions and the synthesis of complex organic molecules. Currently serving as the CEO of Hoortash Daneh Karmania Company, she leads efforts in designing and producing new drugs, particularly anti-cancer drugs and drug carriers. Alongside her industry role, Dr. Mosaddegh holds the position of Associate Professor at the Graduate University of Advanced Technology, where she actively contributes to teaching, research, and academic leadership. Her research interests lie in medicinal chemistry, drug development, and synthesis methodologies, with a focus on addressing societal challenges through innovative approaches in organic chemistry. Dr. Mosaddegh’s multidisciplinary expertise, leadership abilities, and dedication to scientific research make her a valuable contributor to academia, industry, and the advancement of pharmaceutical sciences.

PUBLICATION PROFILE:

Scopus Profile

EDUCATION:

Bachelor of Science (B.Sc.) in Chemistry

  • University: University of Sistan & Baluchestan

Master of Science (M.Sc.) in Organic Chemistry

  • University: University of Sistan & Baluchestan
  • Thesis Title: Study of acetylenic esters reactions with triphenylphosphine in the presence of five-membered heterocycles containing nitrogen
  • Year: May 2003

Doctor of Philosophy (Ph.D.) in Organic Chemistry

  • University: Shahid Bahonar University of Kerman
  • Thesis Title: Study of multi-component reactions in the presence of different catalysts and design new and simple methods for synthesis
  • Year: May 2009

PROFESSIONAL EXPERIENCE:

Assoc Prof Dr. Elaheh Mosaddegh is a distinguished academician and researcher with a wealth of professional experience in the fields of organic chemistry, pharmaceuticals, and academia. Currently serving as the CEO of Hoortash Daneh Karmania Company, she leads efforts in designing and producing new drugs, particularly anti-cancer drugs and drug carriers, while also localizing technical knowledge for producing imported drugs. Alongside her role as CEO, Dr. Mosaddegh holds the position of Associate Professor and faculty member at the Graduate University of Advanced Technology, where she actively contributes to teaching, research, and academic leadership. Her extensive experience also includes serving as the Director of the Office of Scientific Cooperation and International Relations at the Graduate University of Advanced Technology, where she oversaw scientific cooperation initiatives and international relations efforts. Dr. Mosaddegh has further demonstrated her leadership and expertise by organizing and chairing conferences on multi-component reactions and medicinal chemistry, highlighting her commitment to advancing scientific knowledge and fostering collaboration within the academic community.

RESEARCH INTEREST:

Assoc Prof Dr. Elaheh Mosaddegh’s research interests encompass a diverse range of topics within the field of organic chemistry, with a particular focus on medicinal chemistry, drug development, and synthesis methodologies. Her research endeavors include investigating multi-component reactions and the development of new and efficient synthetic methodologies for the synthesis of complex organic molecules. Additionally, she is interested in the design and synthesis of novel drug candidates, with a special emphasis on anti-cancer drugs and drug carriers. Dr. Mosaddegh’s research also extends to exploring the applications of organic chemistry in addressing societal challenges, such as sustainable development and rural development. Overall, her research interests reflect a commitment to advancing scientific knowledge and addressing critical issues in healthcare and sustainable development through innovative approaches in organic chemistry.

PUBLICATION TOP NOTES:

Title: Synthesis and characterization of a novel organosilane-functionalized chitosan nanocarrier as an efficient gene delivery system: Expression of green fluorescent protein

  • Authors: Kashkouli, K.I., Torkzadeh-Mahani, M., Mosaddegh, E.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2019
  • Volume: 125
  • Pages: 143–148
  • Citation count: 8

Title: Immobilization of Penaeus vannamei protease on ZnO nanoparticles for long-term use

  • Authors: Diyanat, S., Homaei, A., Mosaddegh, E.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2018
  • Volume: 118
  • Pages: 92–98
  • Citation count: 44

Title: Synthesis and characterization of aminotetrazole-functionalized magnetic chitosan nanocomposite as a novel nanocarrier for targeted gene delivery

  • Authors: Iravani Kashkouli, K., Torkzadeh-Mahani, M., Mosaddegh, E.
  • Journal: Materials Science and Engineering C
  • Year: 2018
  • Volume: 89
  • Pages: 166–174
  • Citation count: 40

Title: Penaeus vannamei protease stabilizing process of ZnS nanoparticles

  • Authors: Razzaghi, M., Homaei, A., Mosaddegh, E.
  • Journal: International Journal of Biological Macromolecules
  • Year: 2018
  • Volume: 112
  • Pages: 509–515
  • Citation count: 20

Title: A clean and highly efficient synthesis of 4,4′-(arylmethylene)bis(3-methyl-1-phenyl-1H-pyrazol-5-ols) using Ce(SO4)2.4H2O as heterogeneous catalyst

  • Authors: Mosaddegh, E., Islami, M.R., Shojaie, Z.
  • Journal: Arabian Journal of Chemistry
  • Year: 2017
  • Volume: 10
  • Pages: S1200–S1203
  • Citation count: 11
Elaheh Mosaddegh | Medicinal Chemistry Award | Best Researcher Award

You May Also Like